BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4376995)

  • 41. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
    Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
    Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies against enteroviruses in intravenous Ig preparations: great variation in titres and poor correlation with the incidence of circulating serotypes.
    Galama JM; Vogels MT; Jansen GH; Gielen M; Heessen FW
    J Med Virol; 1997 Nov; 53(3):273-6. PubMed ID: 9365895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Letter: Titration of measles and rubella antibody in rheumatoid arthritis].
    Ghozlan R; Amor B; Delbare F
    Nouv Presse Med; 1974 Jun; 3(25):1615. PubMed ID: 4844089
    [No Abstract]   [Full Text] [Related]  

  • 44. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist.
    Konishi E; Shoda M; Kondo T
    Vaccine; 2006 Jan; 24(4):516-24. PubMed ID: 16129523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inactivated combined Coxsackie A-9 and B-1 as well as Echo-6 vaccine. II. Immunogenicity of the combined vaccine].
    Biernacki M; Jabloński L
    Med Dosw Mikrobiol; 1974; 26(4):347-50. PubMed ID: 4475337
    [No Abstract]   [Full Text] [Related]  

  • 47. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathophysiological background of transient hyperphosphatasemia].
    Suzuki M; Okazaki T; Asahara M; Kadohno N; Kanno T
    Rinsho Byori; 1998 Jan; 46(1):88-90. PubMed ID: 9492545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral antibody titers to rubella and rubeola in juvenile rheumatoid arthritis.
    Cassidy JT; Shillis JL; Brandon FB; Sullivan DB; Brackett RG
    Pediatrics; 1974 Aug; 54(2):239-44. PubMed ID: 4603277
    [No Abstract]   [Full Text] [Related]  

  • 50. [Humoral and cellular immunity to selected viral antigens in children from the Bełchatów Industrial Region].
    Stempień R; Słowińska I; Wardecka J; Deroń Z; Imbs D; Jankowski M; Jarzabek Z; Kańtoch M
    Med Dosw Mikrobiol; 1983; 35(3-4):259-68. PubMed ID: 6676608
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia.
    MacCallum FO
    Spec Rep Ser Med Res Counc (G B); 1971; 310():72-85. PubMed ID: 4324778
    [No Abstract]   [Full Text] [Related]  

  • 52. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
    J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey of a medically indigent population in South Dallas, Texas, 1969.
    Thompson L; Luby JP; Barnett JA; Dewlett HJ; Vandersloot J; Reavis LD; Reagan SC
    HSMHA Health Rep; 1971 Nov; 86(11):981-9. PubMed ID: 5138285
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence for persistence of infectious agents in isolated human populations.
    Black FL; Hierholzer WJ; Pinheiro F; Evans AS; Woodall JP; Opton EM; Emmons JE; West BS; Edsall G; Downs WG; Wallace GD
    Am J Epidemiol; 1974 Sep; 100(3):230-50. PubMed ID: 4370011
    [No Abstract]   [Full Text] [Related]  

  • 56. Antibodies against commonly isolated enteroviruses in sera from cases of epidemic encehalitis and contacts (Lucknow).
    Nanda BK; Paul S; Gupta NP
    J Postgrad Med; 1969 Jul; 15(3):120-4. PubMed ID: 4314889
    [No Abstract]   [Full Text] [Related]  

  • 57. [The study of a specific activity of a new allogenic antidiphterial immunoglobulin].
    Fedorovs'ka OO; Mel'nyk OA
    Lik Sprava; 2002; (5-6):89-91. PubMed ID: 12442534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total serum immunoglobulins in Japanese encephalitis patients with high IgE levels in acute phase.
    Shaikh BH; Pavri KM; Ramamoorthy CL; Verma SP; Deuskar NJ
    Indian J Med Res; 1983 Jun; 77():765-9. PubMed ID: 6315575
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bacterial and viral antibodies in human immunoglobulin preparations. II. Viral antibodies].
    Albrycht H; Wysokińska T; Imbs D; Sporzyńska Z; Bucholc B
    Med Dosw Mikrobiol; 1978; 30(3):149-56. PubMed ID: 713634
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intensity of immunity to diphtheria and whooping cough in children and adolescents who have sustained or are currently ill with measles].
    Klots VI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Mar; (3):145-6. PubMed ID: 665034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.